NATIONAL MILITARY AND FIRST RESPONDER-SERVING NONPROFIT OPENS FIRST-OF-ITS-KIND WELLNESS CENTER IN EL PASO, TEXAS

El Paso, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) — El Paso, Texas [November 13, 2025] – Endeavors, a national nonprofit and one of the top three veteran service providers in Texas, officially opened the doors to its first-of-its-kind Health & Wellness Center in El Paso, Texas. The milestone marks the expansion of Endeavors' nationally recognized […]

NATIONAL MILITARY AND FIRST RESPONDER-SERVING NONPROFIT OPENS FIRST-OF-ITS-KIND WELLNESS CENTER IN EL PASO, TEXAS

NATIONAL MILITARY AND FIRST RESPONDER-SERVING NONPROFIT OPENS FIRST-OF-ITS-KIND WELLNESS CENTER IN EL PASO, TEXAS GlobeNewswire November 14, 2025 El Paso, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) — El Paso, Texas [November 13, 2025] – Endeavors, a national nonprofit and one of the top three veteran service providers in Texas, officially opened the doors to its

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

(NASDAQ:MGRX), Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) is issuing the following clarification regarding its press release issued earlier this morning titled “Mangoceuticals Partners with Eli Lilly and Novo Nordisk…”. The newly launched Mangoceuticals weight-management programs MangoRx Direct and PeachesRx Direct are licensed and approved to

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs GlobeNewswire November 14, 2025 Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) is issuing the following clarification regarding its press release issued earlier this morning titled “Mangoceuticals Partners with Eli Lilly and Novo Nordisk…”. The newly launched

Else Nutrition Reschedules 2025 Third Quarter Business Update Conference Call

Conference Call will Now be Held on Monday, November 17th at 10:00 AM Eastern Time ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”),today announced the rescheduling of its business update conference call to 10:00 a.m. Eastern Time on Monday, November 17, 2025. The Company will discuss its financial results for the third

Hormel Foods Corporation (HRL) Under Investigation For Potential Securities Law Violations – Contact Levi & Korsinsky Today

NEW YORK, NY / ACCESS Newswire / November 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Hormel Foods Corporation ("Hormel Foods Corporation") (NYSE:HRL) concerning possible violations of federal securities laws. The Wall Street Journal published an article on October 29, 2025, entitled "Hormel Cuts Forecast on Price Pressure,

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

(Brussels:NYXH),(NasdaqGM:NYXH), INSIDE INFORMATIONREGULATED INFORMATION Correction and Replacement Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio Financings are comprised of equity investments, including from Cochlear, Resmed and Nyxoah's Chairman and Management, and a convertible bond. This press release replaces the press release issued on November 13, 2025, at

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio GlobeNewswire November 14, 2025 INSIDE INFORMATIONREGULATED INFORMATION Correction and Replacement Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio Financings are comprised of equity investments, including from Cochlear, Resmed and Nyxoah's Chairman

Weyerhaeuser Company Declares Dividend on Common Shares

Weyerhaeuser Company(NYSE: WY) today announced that its board of directors declared a quarterly base cash dividend of $0.21 per share on the common stock of the company, payable in cash on December 12, 2025, to holders of record of such common stock as of the close of business on November 28, 2025. https://mma.prnewswire.com/media/321594/WEYERHAEUSER_LOGO.jpg Under Weyerhaeuser's

Smith-Midland Reports Third Quarter 2025 Financial Results

Product Sales Increased 11 Percent and Record Nine-Month Net Income MIDLAND, VA / ACCESS Newswire / November 13, 2025 / Smith-Midland Corporation (NASDAQ:SMID), a provider of innovative, high-quality proprietary and patented precast concrete products and systems, today announced its third quarter results for the period ended September 30, 2025. Third Quarter 2025 Summary (compared to

Scroll to Top